Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

December 6, 2023

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Neovascular Age-related Macular Degeneration (nAMD)
Interventions
DRUG

AR-14034 SR implant lower dose

AR-14034 SR administered as an intravitreal implant

DRUG

AR-14034 SR implant higher dose

AR-14034 SR administered as an intravitreal implant

DRUG

AR-14034 SR implant

AR-14034 SR administered as an intravitreal implant

DRUG

Aflibercept Injection

Aflibercept administered as a 2 milligram (mg) intravitreal injection

DRUG

Sham procedure

Needleless syringe used to simulate an intravitreal injection

Trial Locations (42)

11375

RECRUITING

NYC Retina - Queens, Forest Hills

16507

RECRUITING

Erie Retina Research, Erie

19107

RECRUITING

MidAtlantic Retina Research, Philadelphia

29464

RECRUITING

Carolina Eyecare Physicians LLC, Mt. Pleasant

29605

RECRUITING

Retina Consultants of Carolina, Greenville

30328

RECRUITING

Thomas Eye Group Main Office, Sandy Springs

30909

NOT_YET_RECRUITING

Southeast Retina Center, Augusta

32216

NOT_YET_RECRUITING

Florida Retina Institute, Jacksonville

32503

RECRUITING

Retina Specialty Institute, Pensacola

32757

NOT_YET_RECRUITING

Mid Florida Eye Center, Mt. Dora

32806

RECRUITING

Florida Retina Institute, Orlando

33782

RECRUITING

Eye Associates of Pinellas, Pinellas Park

33880

RECRUITING

Center for Retina and Macular Disease, Winter Haven

36301

RECRUITING

Trinity Research Group, Dothan

39110

RECRUITING

Mississippi Retina Associates, Madison

44106

NOT_YET_RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

55433

RECRUITING

Twin Cities Eye Consultants, Coon Rapids

60452

RECRUITING

University Retina and Macula Associates, PC, Oak Forest

75231

RECRUITING

Texas Retina Associates, Dallas

76012

NOT_YET_RECRUITING

Texas Retina Associates - Arlington, Arlington

76028

NOT_YET_RECRUITING

Star Vision Research, Burleson

77027

NOT_YET_RECRUITING

Berkeley Eye Center, Houston

78251

NOT_YET_RECRUITING

Retina Consultants of Texas - San Antonio, San Antonio

78666

NOT_YET_RECRUITING

Austin Retina Associates (San Marcos), San Marcos

78705

RECRUITING

Austin Research Center for Retina, Austin

RECRUITING

Austin Retina Associates, Austin

78750

RECRUITING

Austin Clinical Research, LLC, Austin

79606

RECRUITING

Retina Research Institute of Texas, Abilene

80809

RECRUITING

Retina Consultants of Southern Colorado, Colorado Springs

84790

NOT_YET_RECRUITING

Retina Research Center of Southern Utah, St. George

85020

RECRUITING

Associated Retina Consultants - Phoenix, Phoenix

85297

RECRUITING

Associated Retina Consultants - Gilbert, Gilbert

85704

RECRUITING

Retina Associates of SW PC, Tucson

87109

NOT_YET_RECRUITING

Vision Research Center Eye Associates of New Mexico, Albuquerque

91436

NOT_YET_RECRUITING

The Retina Partners, Encino

92653

RECRUITING

Retina Associates of Orange County, Laguna Hills

92663

NOT_YET_RECRUITING

Eye Research Foundation, Newport Beach

94040

RECRUITING

Northern California Retina Vitreous Associates Medical Group, Mountain View

97401

RECRUITING

Verum Research, LLC, Eugene

98233

RECRUITING

Pacific Northwest Retina, Burlington

99107

NOT_YET_RECRUITING

Azul Vision Pasadena, Pasadena

Connecticut

RECRUITING

"Retina Group of New England , Waterford"

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT05769153 - Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) | Biotech Hunter | Biotech Hunter